Ventricular assist device infections

Current Infectious Disease Reports

Volumn 14, Issue 4, 2012, Pages 359-366

  Spelman, D ^a   Esmore, D ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Bacteraemia; Driveline infection; Pocket infection; Ventricular assist device

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOODSTREAM INFECTION; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE INFECTION; DISEASE SEVERITY; ENDOCARDITIS; HEART ASSIST DEVICE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; OUTCOME ASSESSMENT; PATHOGENESIS; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREVALENCE; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84865622199     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-012-0261-9     Document Type: Article

References (57)

1. Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist devicerelated infections. Lancet Infect Dis. 2006;6:426-37.
2. Litmathe J, Boeken U, Feindt P, Marktanner R, Gams E. Mechanical assist devices as bridging systems to transplantation: A current review, possible risks, and perspectives. Transplant Proc. 2004;36:3123-8. (Pubitemid 41126756)
3. Zierer A, Melby SJ, Voeller RK, et al. Late-onset driveline infections: The Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg. 2007;84:515-20. (Pubitemid 47069197)
4. Stein ML, Robbins R, Sabati AA, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)-defined morbidity and mortality associated with pediatric ventricular assist device support at a single US center: The Stanford experience. Circ Heart Fail. 2010;3:682-8. This is a significant report of VAD experience in a paediatric population.
5. Organ Procurement and Transplantation and the Scientific Registry of Transplant Recipients. 2008;Chapter V!. Heart Transplantation in the United States 1999-2008 1-14.
6. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-Term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-43.
7. Mancini D, Lietz K. Selection of cardiac transplantation candidates in. Circulation. 2010;122:173-83.
8. Birks EJ. The comparative use of ventricular assist devices: Differences between Europe and the United States. Texas Heart Institute journal/from the Texas Heart Institute of St;37:565-567
9. Fischer SA, Trenholme GM, Costanzo MR, Piccione W. Infectious complications in left ventricular assist device recipients. Clin Infect Dis. 1997;24:18-23. (Pubitemid 27023667)
10. Frazier OH. Unforeseen consequences of therapy with continuousflow pumps. Circ Heart Fail. 2010;3:647-9.
11. Holman WL, Dasse KA. Highlights of the American society for artificial internal organs 2010 conference. Artif Organs. 2010;34:795-7.
12. Holman WL, Pamboukian SV, McGiffin DC, et al. Device related infections: Are we making progress? J Card Surg. 2010;25:478-83. This is an INTERMACS report of infection in pulsatile devices including aetiology, timing and impact on survival.
13. Topkara VK, Kondareddy S, Malik F, et al. Infectious complications in patients with left ventricular assist device: Etiology and outcomes in the continuous-flow era. Ann Thorac Surg. 2010;90:1270-7. The authors report that most non VAD related infection occurred prior to hospital discharge, whereas most VAD related infections occurred following discharge.
14. Esmore D, Spratt P, Larbalestier R, et al. VentrAssist left ventricular assist device: Clinical trial results and Clinical Development Plan update. Eur J Cardiothorac Surg. 2007;32:735-44. (Pubitemid 47513516)
15. Frazier OH, Gemmato C, Myers TJ, et al. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J. 2007;34:275-81. (Pubitemid 350057567)
16. Strueber M, O'Driscoll G, Jansz P, et al. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol. 2011;57:1375-82.
17. Slaughter MS, Giridharan GA, Tamez D, et al. Transapical miniaturized ventricular assist device: Design and initial testing. J Thorac Cardiovasc Surg. 2011;142:668-74. 18. 9.
18. Hannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant. 2011;30:375-84. This is a description of the proposed standardized definition of infections with VAD, produced by the International Society for Heart and Lung Transplantation. (ISHLT).
19. Holman WL, Pamboukian SV, Blood M, et al. Managing device infections: Are we progressing or is infection an insurmountable obstacle? ASAIO J. 2005;51:452-5. (Pubitemid 41076782)
20. Holman WL, Rayburn BK, McGiffin DC, et al. Infection in ventricular assist devices: Prevention and treatment. Ann Thorac Surg. 2003;75:S48-57. (Pubitemid 36677190)
21. Gordon SM, Schmitt SK, Jacobs M, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg. 2001;72:725-30. (Pubitemid 32846217)
22. PaeWE, Connell JM,AdelowoA, et al. Doestotal implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant. 2007;26:219-29. (Pubitemid 46341881)
23. Sasaoka T, Kato TS, Komamura K, et al. Improved long-Term performance of pulsatile extracorporeal left ventricular assist device. J Cardiol. 2010;56:220-8.
24. Genovese EA, Dew MA, Teuteberg JJ, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg. 2009;88:1162-70.
25. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1-10. This INTERMACS Annual Report includes>1000 VAD implants between 2006 and 2009 and demonstrated a significantly lower rate of infection with continuous flow compared with pulsatile devices.
26. Schaffer JM, Allen JG, Weiss ES, et al. Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. J Heart Lung Transplant. 2011;30:164-74. The authors give an outline of causative micro-organisms stratified by site.
27. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-51. The authors demonstrated a decrease in device related and non device related infections and sepsis with continuous flow compared with pulsatile flow devices.
28. Bagdasarian NG, Malani AN, Pagani FD, Malani PN. Fungemia associated with left ventricular assist device support. J Card Surg. 2009;24:763-5.
29. Saito S,Matsumiya G, Sakaguchi T, et al. Risk factor analysis of longterm support with left ventricular assist system. Circ J. 2010;74:715-22.
30. Simon D, Fischer S, Grossman A, et al. Left ventricular assist device-related infection: Treatment and outcome. Clin Infect Dis. 2005;40:1108-15. (Pubitemid 40490234)
31. Smedira NG, Hoercher KJ, Yoon DY, et al. Bridge to transplant experience: Factors influencing survival to and after cardiac transplant. J Thorac Cardiovasc Surg. 2010;139:1295-1305, 1305 e1291-1294.
32. MorshuisM, El-Banayosy A, Arusoglu L, et al. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg. 2009;35:1020-7. discussion 1027-1028.
33. Monkowski DH, Axelrod P, Fekete T, et al. Infections associated with ventricular assist devices: Epidemiology and effect on prognosis after transplantation. Transpl Infect Dis. 2007;9:114-20. (Pubitemid 46669080)
34. Herrmann M, Weyand M, Greshake B, et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation. 1997;95:814-7. (Pubitemid 27091519)
35. Gogas BD, Parissis JT, Iliodromitis EK, et al. Left ventricular assist device vegetation: "cure" without device explantation. Hellenic J Cardiol. 2010;51:549-51.
36. Holman WL, Kirklin JK, Naftel DC, et al. Infection after implantation of pulsatile mechanical circulatory support devices. J Thorac Cardiovasc Surg. 2010;139:1632-6. e1632.
37. Aslam S, Hernandez M, Thornby J, Zeluff B, Darouiche RO. Risk factors and outcomes of fungal ventricular-Assist device infections. Clin Infect Dis. 2010;50:664-71.
38. Carr CM, Jacob J, Park SJ, et al. CT of left ventricular assist devices. Radiographics. 2010;30:429-44.
39. Litzler PY, Manrique A, Etienne M, et al. Leukocyte SPECT/CT for detecting infection of left-ventricular-Assist devices: Preliminary results. J Nucl Med. 2010;51:1044-8.
40. Beiras-Fernandez A, Kur F, Kiefer S, et al. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: The role of daptomycin. Transplant Proc. 2009;41:2589-91.
41. Spelman DHD, Esmore D, et al. Heterogeneous vancomycinintermediate Staphylococcus aureus (hVISA) bacteremia in patients with Ventricular Assist Devices (VAD): A case series. Presented at 11th International Society of Cardiovascular Infectious Diseases, Cairns, Australia; 24th-26th July 2011. 2011
42. Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant. 1997;16:822-31. (Pubitemid 27362682)
43. Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: Prevention and management of left ventricular assist device infections. ASAIO J. 2005;51:461-70. (Pubitemid 41076784)
44. Saito S, Matsumiya G, Sakaguchi T, et al. Long-Term medical control of inflow cuff infection in a patient with a left ventricular assist system. J Artif Organs. 2009;12:58-60.
45. Kouretas PC, Burch PT, Kaza AK, et al. Management of deep wound complications with vacuum-Assisted therapy after Berlin Heart EXCOR ventricular assist device placement in the pediatric population. Artif Organs. 2009;33:922-5.
46. Mekontso-Dessap A, Kirsch M, Vermes E, et al. Nosocomial infections occurring during receipt of circulatory support with the paracorporeal ventricular assist system. Clin Infect Dis. 2002;35:1308-15. (Pubitemid 35448957)
47. Holman WL, Kormos RL, Naftel DC, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: A multi-institutional study. J Heart Lung Transplant. 2009;28:44-50.
48. Sinha P, Chen JM, Flannery M, et al. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation 2000;102:III194-199
49. Oz MC, Argenziano M, Catanese KA, et al. Bridge experience with long-Term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation. 1997;95:1844-52. (Pubitemid 27164402)
50. Schulman AR, Martens TP, Russo MJ, et al. Effect of left ventricular assist device infection on post-Transplant outcomes. J Heart Lung Transplant. 2009;28:237-42. This is a report of the impact of VAD infection on pre-Transplant and post transplant survival.
51. Holman WL, Park SJ, Long JW, et al. Infection in permanent circulatory support: Experience from the REMATCH trial. J Heart Lung Transplant. 2004;23:1359-65. (Pubitemid 40018157)
52. Walker PC, DePestel DD, Miles NA, Malani PN. Surgical infection prophylaxis for left ventricular assist device implantation. J Card Surg. 2011;26:440-3.
53. Eyler RF, Butler SO, Walker PC, et al. Vancomycin use during left ventricular assist device support. Infect Control Hosp Epidemiol. 2009;30:484-6.
54. Hernandez MD, Mansouri MD, Aslam S, Zeluff B, Darouiche RO. Efficacy of combination of N-Acetylcysteine, gentamicin, and amphotericin B for prevention of microbial colonization of ventricular assist devices. Infect Control Hosp Epidemiol. 2009;30:190-2.
55. Choi L, Choudhri AF, Pillarisetty VG, et al. Development of an infection-resistant LVAD driveline: A novel approach to the prevention of device-related infections. J Heart Lung Transplant. 1999;18:1103-10.
56. Malani PN, Dyke DB, Pagani FD, Chenoweth CE. Nosocomial infections in left ventricular assist device recipients. Clin Infect Dis. 2002;34:1295-300. (Pubitemid 34507937)
57. Poston RS, Husain S, Sorce D, et al. LVAD bloodstream infections: Therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant. 2003;22:914-21. (Pubitemid 36945491)